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Spirochaetes today are often sidelined as an interesting
exception within the microbial world, yet spirochaetes have
played a major role in our understanding of microbial patho-
genesis. As a group, they have challenged our established
understanding of microbial infections, and still have a pleth-
ora of other secrets to disclose. Within this themed issue,
we examine a range of spirochaetal examples, ranging from
relapsing fever, the expanding group of Borrelia burgdorferi
sensu lato, through to Leptospira and the complex polymicro-
bial role of oral treponemes in causing periodontitis. Each of
these examples provides challenges to our accepted views
and thus serves to stimulate new concepts, adding to our
understanding of the mechanisms of pathogenesis.
The impact of spirochaetal infections on human health
became well established in Europe following the return of
the conquistadores from America. Starting in 1493 in Barce-
lona, syphilis, which was originally called ‘Spanish disease’,
rapidly spread throughout Europe. As such, this spirochaete
was the focus of many early therapeutic efforts with mercury
(with or without various local remedies), thus laying the
foundations for the ﬁght against infectious diseases. The aeti-
ological agent ‘Spirochaeta pallida’ (now Treponema pallidum)
was discovered by the German zoologist Fritz Schaudinn in
1905. This opened the ﬂoodgates for development of diag-
nostics and improved arsenical therapeutics [1]. This discov-
ery was part of ‘the golden age’ of German microbiological
discovery of the 19th century and early 20th century. Our
ﬁrst review, by Wright and Boyce [2], describes some of
these early milestone discoveries related to Borrelia that have
paved the way for microbiologists of the current era. Follow-
ing Ehrenberg’s original recognition of the Spirochaetae as a
new phylum (cited by Wright and Boyce) [2], the pathogenic
potential of its members was ﬁrst revealed by Obermeier in
1866 (cited in Wright and Boyce) [2]. To further clarify this
pathogenic potential, animal inoculation was attempted, but
this, unlike for many infectious agents under study at this
time, proved unsuccessful, because of the host speciﬁcity of
these spirochaetes. Several microbiologists subsequently
engaged in self-inoculation, eventually establishing a patho-
genic role for Borrelia recurentis, the cause of louse-borne
relapsing fever.
More recently, emphasis has shifted towards another bor-
relial infection, that of Lyme borreliosis. Wright and Boyce
[2] continue through to the current German spirochaetolo-
gists, who remain at the forefront of signiﬁcant research
efforts, particularly the delineation of new genospecies and
the deciphering of host–spirochaete immune interactions.
This theme is further expanded in relation to the many new
species now recognized within the B. burgdorferi sensu lato
complex. The review by Stanek and Reiter [3] updates our
recognition of the increasing genospecies within the Lyme
Borrelia complex. Of these, those with established pathoge-
nicity for humans include Borrelia afzelii, B. burgdorferi sensu
stricto and Borrelia garinii [4]; however, some of the more
recently recognized genospecies, such as Borrelia bissettii, Bor-
relia lusitaniae, Borrelia spielmanii and Borrelia valaisiana, have
been implicated as potential pathogens. As discussed by Sta-
nek and Reiter, [3] the contribution of these new members
to the clinical manifestations of Lyme borreliosis remains to
be fully elucidated. Conversely, their role might be merely
that of complicating the diagnosis of genuine cases through
stimulation of cross-reactive serology.
The application of molecular typing to the Lyme Borrelia
complex has not only revealed the heterogeneity between
genospecies, but has, signiﬁcantly, also been used to subtype
within genospecies. Stanek and Reiter [3] describe how this
has disclosed correlations of particular genotypes with invasive
disease, and this might, in the future, yield greater insights into
the pathogenici mechanisms employed by these spirochaetes.
The differential host susceptibility seen among both relaps-
ing fever and Lyme borreliae has stimulated signiﬁcant
research interest. Over recent years, the interaction of these
spirochaetes with various immune mediators, such as fac-
tor H and factor H-like proteins, binding of host plasminogen
and subsequent hypothesized mechanisms of complement
evasion have been of considerable interest [5–9]. These
mechanisms are in addition to the antigenic variation (either
through whole gene replacement or modulation of gene cas-
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settes) for which borreliae have provided an exemplary
example for many years [10,11].
Spirochaetal diversity is a theme continued by our other
reviewed examples. Hartskeerl et al. [12] highlight the
enormity of the global threat of leptospirosis. These authors
describe this truly global zoonosis, which appears to be re-
emerging, with notable outbreaks over recent years in Nica-
ragua, Sri Lanka and the Philippines. However, possible lepto-
spirosis is often only considered as an afterthought, if indeed
it is considered at all. In part, this is encouraged through its
ability to clinically mimic other conditions that are generally
deemed to be of greater importance for the healthcare
agenda. Lack of surveillance in either human or livestock
populations make it difﬁcult to map the true extent of the
problem, with the data available being a gross underestima-
tion of the true burden of infection. Hartskeerl et al. [12]
describe how the pathogenic serovars of Leptospira have now
expanded to nearly 300, often showing distinct host adapta-
tions. In their natural host, they persist with little clinical
consequence (including, often, a failure to produce a serolog-
ical response), and are excreted through the urine into the
environment, whereby they can be acquired by ‘accidental’
hosts such as humans. It is here that the impact of infection
becomes apparent. Despite our knowledge of acute clinical
manifestations, we know almost nothing about the late con-
sequences of infection. In the review of Hartskeerl et al.
[12], it is proposed that 27% of human cases have long-term
complaints, of which 11% were serious, and 1.3% caused the
patients to remain permanently unﬁt to work.
Hartskeerl et al. describe infection control that has been
targeted to speciﬁc hosts, such as cattle and companion ani-
mals; however, our simplistic view of control of zoonoses by
reducing infection in the reservoir host may be somewhat
short-sighted. The dynamics that inﬂuence which leptospires
reside in which host species are both complex and currently
poorly understood. Alarmingly, reduction of a targeted ser-
ovar in a particular host species through vaccination might
encourage selective pressure and adaptation of other sero-
vars to these hosts. Similarly, populating new areas with
non-indigenous species, as is common practice in farming,
could result in changes in both the distribution and disease
patterns of leptospirosis.
Hartskeerl et al. [12] go on to discuss the complexity of
detecting cases, arising from lack of suspicion, resulting in
delays (and thus failure to collect optimal samples), the con-
siderable complexity of many of the diagnostic methods for
leptospirosis, and the lack of any reporting system through
which data can be collated and shared. To further complicate
diagnostics, the questions that need answers for human and
livestock cases are not necessarily concordant. For the ﬁrst,
a genus diagnosis will sufﬁce, but for the latter, it is essential
to determine serovar, as this impacts on the likely success of
vaccinational control measures, which are usually serovar-
speciﬁc. The failure of current vaccines to cross-protect and
produce long-term immunity is an area that needs to be
urgently addressed. Although potential improvements
through the introduction of subunit vaccines are likely to be
signiﬁcant for human and companion animals, they are too
expensive for control of infection among livestock.
This review reminds us of the threats resulting from
increasing globalization, and, indeed, the popularity of many
highly endemic areas as tourist attractions where visitors fre-
quently partake in high-risk exposure activities, such as
watersports, jungle treks and caving, must be remembered
when a returning traveller presents with fever [12–14].
Our last spirochaetal example, reviewed by Visser and
Ellen, [15] is one that sounds far less ‘exotic’, but remains
hugely signiﬁcant, namely the oral treponemes. Their clinical
signiﬁcance is suggested through their prominent role in the
aetiology of the polymicrobial infection of periodontitis.
Research efforts have largely focused on the cultivable mem-
bers of the oral treponemes, with Treponema denticola having
a pivotal role in our initial insights into potential virulence
mechanisms and host evasion strategies. Virulence mecha-
nisms that have been elucidated for T. denticola and some of
the less well-known oral treponemes are reviewed [15].
These spirochaetes constitute approximately 1% of the nor-
mal subgingival ﬂora, but, remarkably, this shifts to 50% in
the plaque of periodontitis cases. More than 70% of oral
Treponema phylotypes remain uncultivatable, with only ten
species having been cultivated. Of these, T. denticola has been
best studied, revealing a wealth of factors that enable pene-
tration of host tissues and host evasion [15]. Our under-
standing of the role of these spirochaetes in periodontal
disease has beneﬁted hugely from genomic sequencing efforts
coupled with the ability to use directed genetic manipulation
to study the contributions of various gene products to path-
ogenesis. Spirochaetes in general have been particularly resil-
ient to genetic manipulation, which is considered
commonplace for many other microorganisms.
Oral treponemes need to rapidly outgrow competing
microorganisms within the diseased periodontal pocket. To
facilitate this, they need a comprehensive means of detecting
shifts in the dynamics of their local environment. Through
genomic sequencing efforts, a range of two-component regu-
latory systems have been disclosed that are likely to bring
about this sensory ability. These spirochaetes dedicate
approximately 2% of their whole genomes to chemotaxis
genes, including those encoding chemoreceptors that enable
rapid responses to environmental changes, particularly attr-
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actants such as serum and glucose, which are increased in
diseased periodontal pockets [15]. Within this polymicrobial
environment, there is ample opportunity for genetic
exchange, both between Treponema species and between
genera. This capacity for lateral gene ﬂow is further sup-
ported by the detection of transposases and bacteriophages
in oral treponemes.
Visser and Ellen [15] go on to describe the signiﬁcant
research efforts that have focused on the mechanism of
adhesion of these spirochaetes to the extracellular matrix,
which is essential for the initiation of pathogenesis. Here,
binding to collagen, ﬁbronectin and laminin is important, but
the ability to bind to these appears to be heterogeneous
among oral treponemes. Host damage appears to be medi-
ated through a variety of proteases, such as dentilisin, which
is able to degrade extracellular matrix proteins, and a range
of host immune mediators, which thus provide the dual func-
tions of host damage and immune evasion. Despite trepone-
mal activation of toll-like receptors (TLR2 and TLR4), it is
thought that they may also induce immune tolerance. Inter-
ference with the typical host response to lipopolysaccharide
of other periodontal bacteria has been demonstrated in the
presence of glycolipids and/or phospholipids of oral trepo-
nemes [15].
Thus, from the insights given within these reviews, we can
see that, far from spirochaetes being a rather neglected
microbial ‘special case’, they actually still carry the torch for-
wards in our expanding appreciation of the microbial world
and in deciphering host–microorganism interactions.
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